Previous studies have shown the involvement of the proteasome in the regulation of hSphK1, where novel inhibitors of SphK1-S1P activity induced the proteasomal degradation of this protein in prostate cancer cell lines [266]. The gene discussed is SPHK1; the disease is Familial prostate cancer.